"The team at Astera Cancer Care in East Brunswick will help you navigate the complex world of cancer treatment. From initial diagnosis to developing a complete cancer treatment plan, you will have a team of medical oncologists, radiation oncologists, and breast surgeons with you every step of the way. We also offer cancer support care and financial advocacy options as part of our commitment to our patients to provide an unparalleled, supported patient experience."

During the past decade, Astera Cancer Care conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Astera Cancer Care" #1 sponsor was "Epizyme, Inc." with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Astera Cancer Care" #1 collaborator was "ALX Oncology Inc." with 1 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Astera Cancer Care" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Neoplasms" (2 trials), "Lymphoma, Large B-Cell, Diffuse" (2 trials), "Lymphoma, Non-Hodgkin" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Astera Cancer Care" in a lesser frequency.

Most popular intervention types in "Astera Cancer Care" are "Drug" (25 trials), "Biological" (2 trials), "Procedure" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Magrolimab" (3 trials), "Paclitaxel" (3 trials), "Amivantamab" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Astera Cancer Care" are 27 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Astera Cancer Care". undefined are not yet recruiting, 16 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Astera Cancer Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Astera Cancer Care, 4 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".